Design, Synthesis & Biological Evaluation of Research Compounds
Our novel molecules program encompasses the rational design, synthesis, and comprehensive in vitro biological evaluation of proprietary research compounds guided by structure-activity relationship analysis and mechanistic hypotheses.
Hypothesis-Driven Compound Development
The novel molecules program at Bluegrass Oncology Advancements LLC is built on a hypothesis-driven approach to compound design. Each research series is initiated with a clearly articulated mechanistic hypothesis, supported by structural analysis of known bioactive scaffolds and computational modeling of target interactions.
Our synthetic chemistry capabilities enable the preparation of structurally diverse compound libraries for systematic SAR exploration. Biological evaluation is conducted using the same validated assay platforms employed in our drug repurposing program, enabling direct comparison of novel compounds with established reference agents.
Structure-Activity Relationship Approach
SAR analysis is conducted systematically across each compound series, with structural modifications designed to probe the contribution of individual functional groups to biological activity. IC₅₀ data across the full cell line panel are used to construct SAR maps that guide iterative compound design and prioritization of synthetic targets.
Active Compound Series Under Development
Benzimidazole Derivatives
The benzimidazole scaffold is a privileged structure in medicinal chemistry with documented activity against multiple cancer-relevant targets including tubulin, topoisomerase II, and kinase enzymes. Our program explores 2-substituted and N-alkylated benzimidazole derivatives for antiproliferative activity.
Chalcone Analogues
Chalcones and their heterocyclic analogues represent a structurally tractable scaffold with broad-spectrum antiproliferative activity. We synthesize and evaluate chalcone derivatives with targeted substitution patterns designed to enhance potency and selectivity against specific cancer cell line models.
Quinoline & Quinoxaline Derivatives
Nitrogen-containing heterocyclic scaffolds with established precedent in oncology drug discovery. Our program explores novel substitution patterns on quinoline and quinoxaline cores, guided by SAR data from the existing literature and our own experimental findings.
Hybrid Pharmacophore Compounds
Molecular hybridization of pharmacophoric elements from two or more bioactive scaffolds to generate compounds with potentially enhanced potency or dual-mechanism activity. Hybrid design is guided by mechanistic rationale and computational docking analysis.